Lv1
80 积分 2025-11-26 加入
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma
2个月前
已完结
Evaluating Safety and Effectiveness of Switching Biologics in Managing Severe Asthma Patients
2个月前
已完结
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
2个月前
已完结
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
2个月前
已完结
Steroid-resistant asthma
2个月前
已完结
Remission in the World of Severe Asthma
2个月前
已完结
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma
4个月前
已完结
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
4个月前
已完结
2025 GINA report for asthma
6个月前
已完结
皖公网安备34019202002308
